These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30277753)

  • 1. Mechanistic Insight into the Binding Profile of DCVJ and α-Synuclein Fibril Revealed by Multiscale Simulations.
    Kuang G; Murugan NA; Ågren H
    ACS Chem Neurosci; 2019 Jan; 10(1):610-617. PubMed ID: 30277753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease.
    Covell DJ; Robinson JL; Akhtar RS; Grossman M; Weintraub D; Bucklin HM; Pitkin RM; Riddle D; Yousef A; Trojanowski JQ; Lee VM
    Neuropathol Appl Neurobiol; 2017 Dec; 43(7):604-620. PubMed ID: 28386933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Analysis of the Conformation, Aggregation, Interaction, and Fibril Morphologies of Human α-, β-, and γ-Synuclein Proteins.
    Jain MK; Singh P; Roy S; Bhat R
    Biochemistry; 2018 Jul; 57(26):3830-3848. PubMed ID: 29851342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational Insight into the Binding Profile of the Second-Generation PET Tracer PI2620 with Tau Fibrils.
    Kuang G; Murugan NA; Zhou Y; Nordberg A; Ågren H
    ACS Chem Neurosci; 2020 Mar; 11(6):900-908. PubMed ID: 32069017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration.
    Mahul-Mellier AL; Burtscher J; Maharjan N; Weerens L; Croisier M; Kuttler F; Leleu M; Knott GW; Lashuel HA
    Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4971-4982. PubMed ID: 32075919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrillar form of α-synuclein-specific scFv antibody inhibits α-synuclein seeds induced aggregation and toxicity.
    Gupta V; Salim S; Hmila I; Vaikath NN; Sudhakaran IP; Ghanem SS; Majbour NK; Abdulla SA; Emara MM; Abdesselem HB; Lukacsovich T; Erskine D; El-Agnaf OMA
    Sci Rep; 2020 May; 10(1):8137. PubMed ID: 32424162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid-liquid Phase Separation of α-Synuclein: A New Mechanistic Insight for α-Synuclein Aggregation Associated with Parkinson's Disease Pathogenesis.
    Mukherjee S; Sakunthala A; Gadhe L; Poudyal M; Sawner AS; Kadu P; Maji SK
    J Mol Biol; 2023 Jan; 435(1):167713. PubMed ID: 35787838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis.
    Mehra S; Sahay S; Maji SK
    Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):890-908. PubMed ID: 30853581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of the radioligand SIL23 to α-synuclein fibrils in Parkinson disease brain tissue establishes feasibility and screening approaches for developing a Parkinson disease imaging agent.
    Bagchi DP; Yu L; Perlmutter JS; Xu J; Mach RH; Tu Z; Kotzbauer PT
    PLoS One; 2013; 8(2):e55031. PubMed ID: 23405108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unravelling the destabilization potential of ellagic acid on α-synuclein fibrils using molecular dynamics simulations.
    Mankoo OK; Kaur A; Goyal D; Goyal B
    Phys Chem Chem Phys; 2023 Mar; 25(11):8128-8143. PubMed ID: 36877087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigallocatechin Gallate Destabilizes α-Synuclein Fibril by Disrupting the E46-K80 Salt-Bridge and Inter-protofibril Interface.
    Yao Y; Tang Y; Wei G
    ACS Chem Neurosci; 2020 Dec; 11(24):4351-4361. PubMed ID: 33186020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research Progress of α-Synuclein Aggregation Inhibitors for Potential Parkinson's Disease Treatment.
    Kalsoom I; Wang Y; Li B; Wen H
    Mini Rev Med Chem; 2023; 23(20):1959-1974. PubMed ID: 37198991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction between alpha-synuclein and mitochondrial dysfunction in Parkinson's disease.
    Li HY; Liu DS; Zhang YB; Rong H; Zhang XJ
    Biophys Chem; 2023 Dec; 303():107122. PubMed ID: 37839353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of a Julolidine-Based Neutral Ultrafast Molecular Rotor with Natural DNA: Spectroscopic and Molecular Docking Studies.
    Kalel R; Mora AK; Ghosh R; Dhavale DD; Palit DK; Nath S
    J Phys Chem B; 2016 Sep; 120(37):9843-53. PubMed ID: 27559832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology.
    Kumar ST; Jagannath S; Francois C; Vanderstichele H; Stoops E; Lashuel HA
    Neurobiol Dis; 2020 Dec; 146():105086. PubMed ID: 32971232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive fluorescence polarization technique for rapid screening of alpha-synuclein oligomerization/fibrillization inhibitors.
    Luk KC; Hyde EG; Trojanowski JQ; Lee VM
    Biochemistry; 2007 Nov; 46(44):12522-9. PubMed ID: 17927212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular events underlying the cell-to-cell transmission of α-synuclein.
    Choi YR; Park SJ; Park SM
    FEBS J; 2021 Dec; 288(23):6593-6602. PubMed ID: 33332736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brazilin Removes Toxic Alpha-Synuclein and Seeding Competent Assemblies from Parkinson Brain by Altering Conformational Equilibrium.
    Nahass GR; Sun Y; Xu Y; Batchelor M; Reilly M; Benilova I; Kedia N; Spehar K; Sobott F; Sessions RB; Caughey B; Radford SE; Jat PS; Collinge J; Bieschke J
    J Mol Biol; 2021 Apr; 433(8):166878. PubMed ID: 33610557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha Synuclein Fibrils Contain Multiple Binding Sites for Small Molecules.
    Hsieh CJ; Ferrie JJ; Xu K; Lee I; Graham TJA; Tu Z; Yu J; Dhavale D; Kotzbauer P; Petersson EJ; Mach RH
    ACS Chem Neurosci; 2018 Nov; 9(11):2521-2527. PubMed ID: 29750499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Benzothiazole Derivatives as Fluorescent Probes for Detection of β-Amyloid and α-Synuclein Aggregates.
    Watanabe H; Ono M; Ariyoshi T; Katayanagi R; Saji H
    ACS Chem Neurosci; 2017 Aug; 8(8):1656-1662. PubMed ID: 28467708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.